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Purpose: Although early neurological deterioration (END) during the acute stroke 
period is known to be associated with poor functional outcomes, there is little data 
regarding the impact of END on long-term outcomes according to the characteris-
tics of END. The aim of this study was to investigate whether there are differences 
in long-term mortality according to the characteristics of END among acute isch-
emic stroke or transient ischemic attack patients. Materials and Methods: END 
was defined as any increase (≥1) in National Institute of Health Stroke Scale score 
within 7 days after admission. We assessed the characteristics of END, such as the 
etiology and severity of END, as well as recovery after END. The relationship be-
tween 30-day or long-term mortality and each characteristic of END was investi-
gated using multiple logistic analysis or Cox regression model. Results: Among 
2820 patients, END was observed in 344 patients (12.2%). After adjustment for 
age, sex, underlying cardiovascular diseases, stroke severity, and stroke subtypes, 
END was associated with long-term mortality, whether it was mild or severe and 
whether or not it was followed by recovery. However, 30-day mortality was strong-
ly related to the severity of END or the absence of recovery after END. Among the 
causes of END, recurrent stroke and medical illness were related to 30-day mortali-
ty, as well as long-term mortality, while brain herniation and intracranial hemor-
rhagic complications were only associated with 30-day mortality. Conclusion: The 
results of the present study demonstrated that END is associated with higher mor-
tality and the effects of END on short-term and long-term mortality depend on 
END characteristics.
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INTRODUCTION
Stroke is the leading cause of death worldwide. Previous studies have shown that 
the risk of early death during the acute stroke period is 7-20%, and death is caused 
by the direct impact of index stroke or its complications.1-3 However, survivors after 
stroke are also at an increased risk for further strokes and death during long-term 
follow-up.4 The risk of mortality for ischemic stroke patients is related to the initial 
stroke severity and stroke subtype, as well as cardiovascular disease burden.2,5-8  
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1-, 3-, and 7-day NIHSS scores were entered into the stroke 
registry, and these scores were used in this study. If a pa-
tient died or was discharged within 7 days after admission, 
we used the last NIHSS score immediately before death or 
discharge as the final NIHSS score. We also calculated del-
ta NIHSS scores (baseline NIHSS-final NIHSS score). 
For our analysis of the NIHSS scores, END was defined 
as any increase (≥1) in NIHSS score within 7 days after ad-
mission compared with baseline NIHSS score. If patients 
experienced END, we determined the etiology and the se-
verity of END. The causes of END were categorized into 
five groups of brain herniation, worsening of index stroke 
symptoms, recurrent stroke, intracerebral hemorrhage (ICH), 
and medical illness. Recurrent stroke was defined as exhib-
iting new neurologic symptoms with/without documenta-
tion of a new lesion in a different vascular territory on fol-
low-up brain imaging. These classifications were mainly 
determined by a clinician based on additional results of brain 
imaging and medical condition. The severity of END was 
divided into three groups: severe END, with a worsening of 
≥4 in NIHSS score; moderate END, with an increase of ≥2 
and <4 in NIHSS score; and mild END, with an increase of 
1 in NIHSS score, compared with baseline NIHSS score. 
We also investigated whether the patients with END recov-
ered after they had experienced END. Recovery was de-
fined as a final NIHSS score that was lower than or equal to 
the baseline NIHSS score for a given patient.
Long-term mortality
During follow-up, we collected patient data concerning death 
through nationwide death certificate data from the Korean 
National Statistical Office. The national death certification 
data are known to be reliable, according to previous studies,17 
because these data are collected based on a unique 13-digit 
identification code assigned to subjects at birth and the causes 
of death are coded according to the International Classifica-
tion of Disease, 10th Revision. In this study, we defined the 
censoring date as December 31, 2008.
Statistical analysis
Numerical data are given as the mean±standard deviation 
and medians with interquartile range (IQR) for NIHSS scores. 
In this analysis, we investigated which variables were inde-
pendently associated with short-term mortality (30-day mor-
tality) in all ischemic stroke patients and long-term mortality 
in stroke survivors after 30 days. For comparison of 30-day 
mortality, we used multiple binary logistic regression anal-
Early neurological deterioration (END) can occur in about 
10-40% of ischemic stroke patients during the acute stage8-13 
and can be caused by brain herniation due to large cerebral 
infarction, poor collaterals, recurrent stroke, and medical ill-
nesses, including infection, myocardial infarction, and gas-
trointestinal bleeding.14 Although END is known to be asso-
ciated with poor functional outcomes and higher mortality 
during short-term follow-up,11,12,15 there are few data regard-
ing the impacts of END on long-term outcomes, in particu-
lar mortality, according to its characteristics, such as etiolo-
gy, severity, and recovery of neurological worsening, in a 
large stroke population.
The aim of this study was to investigate short-term and 
long-term mortality in ischemic stroke or transient isch-
emic attack (TIA) patients who exhibited deterioration 
during the acute stroke period. We also attempted to deter-
mine whether the characteristics of END have different ef-
fects on mortality. 
MATERIALS AND METHODS
　　　
Study sample 
From January 2000 to December 2008, a total of 4090 pa-
tients who experienced ischemic stroke or TIA were admit-
ted to Yonsei University Hospital, Department of Neurology. 
During admission, all patients were thoroughly evaluated 
through our stroke care pathway, which includes previous 
medical history, neurological status, standard blood tests, 
brain CT/MRI, angiographic studies, and cardiac evalua-
tions. All patient data were prospectively and consecutively 
registered with the Yonsei Stroke Registry.16 For this study, 
we excluded data concerning re-admission for recurrent 
stroke (n=198), presentation to hospital later than 3 days after 
onset of stroke (n=717) or hospitalization for less than 2 days 
(n=6), those who received thrombolytic treatment (n=345), 
and those with missing National Institute of Health Stroke 
Scale (NIHSS) data (n=4). Finally, 2820 patients were in-
cluded in this study. This study was approved by the Insti-
tutional Review Board of Severance Hospital, Yonsei Uni-
versity College of Medicine.
Early neurological course 
During hospitalization, all patients were evaluated daily to 
assess neurological status. All patients were assessed by 
stroke specialists and senior residents to check for neuro-
logical impairment using the NIHSS scores. The baseline, 
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the causes of END, worsening of index stroke symptoms 
(59.9%, 211/352) was most common, followed by recurrent 
stroke (14.8%, 52/352), brain herniation (12.2%, 43/352), 
ICH (9.4%, 33/352), and medical illness (3.7%, 13/352). 
Patients who had experienced mild or moderate END were 
more likely to recover compared with those with severe 
END; the frequency of recovery after END was 51.1% 
(48/94) in mild END, 35.0% (35/100) in moderate END, 
and 7.0% (11/158) in severe END (p<0.001). Of the etiolo-
gies of END, neurological worsening caused by brain her-
niation, ICH, recurrent stroke, and medical illness were 
more frequently associated with severe END. The propor-
ysis with adjustment for potential covariates, which exhibit-
ed a significant association in univariate analysis with a p-
value <0.05. For analysis of long-term mortality in stroke 
survivors, we applied univariate and multivariate Cox pro-
portional hazards models to calculate the hazard ratio (HR) 
and 95% confidence intervals (CIs). The adjusted survival 
curves are presented after adjustment for all variables that 
were significant in the univariate Cox proportional hazards 
model.
In this study, all variables were investigated using the mul-
ticollinearity test. Based on this analysis, baseline NIHSS 
and other NIHSS scores, including final NIHSS score, had a 
strong association, while baseline NIHSS score was not sta-
tistically associated with the delta NIHSS score. Therefore, 
among the NIHSS scores measured at different times, the 
delta NIHSS score and baseline NIHSS score were entered 
into the multivariate model as covariates in the analysis of 
long term mortality.
Finally, all results with p<0.05 were considered statistical-
ly significant. All statistical analyses were conducted with 
the SPSS software package (version 18.0, SPSS Inc., Chica-
go, IL, USA) and the SAS software package (version 9.1.3, 
SAS Inc., Cary, NC, USA).
 
RESULTS
 
Overall baseline characteristics 
Of the 2820 ischemic stroke patients enrolled for this analy-
sis, the mean age was 63.9±11.9 years and 61.5% were male. 
Their median NIHSS score was 3 (IQR 1-6). Seventy-nine 
(2.8%) patients died within 1 month after index stroke, and a 
total of 500 (17.7%) patients were dead after a median fol-
low-up of 3.1 years (range, 2 days-9 years). Baseline charac-
teristics are presented in Table 1.
Characteristics of early neurologic deterioration
END was observed in 352 patients (12.5%). The frequency 
of END decreased as the interval from symptom onset to 
admission increased: the frequency of END was 13.4% 
(284/2126) within 24 hours, 10.4% (47/454) within 24-48 
hours, and 8.8% (21/240) within 48-72 hours (p=0.012). 
Among the entire study population, TIA patients consisted 
of 9.8% and only 1.1% of TIA patients experienced END 
during hospitalization. Among patients with END, most pa-
tients worsened during the first 3 days (88.6%, 312/352) and 
did not recover during hospitalization (73.3%, 258/352). Of 
Table 1. Baseline Characteristics of the Study Population 
(n=2820)
Demographics
    Age, yr 63.9±11.9
    Sex, male 1735 (61.5)
Risk factors
    Hypertension 2101 (74.5)
    Diabetes mellitus   921 (32.7)
    Hyperlipidemia   303 (10.7)
    Smoking 1218 (43.2)
Atrial fibrillation   472 (16.7)
Previous ischemic stroke   483 (17.1)
Previous ischemic heart diseases   412 (14.6)
Peripheral arterial occlusive diseases   37 (1.3)
TOAST classification*
    Small vessel occlusion   380 (13.5)
    Large artery atherosclerosis   606 (21.5)
    Cardioembolism   518 (18.4)
    Stroke of other determined etiology   49 (1.7)
    Undetermined   992 (35.2)
Medication during admission
    Antiplatelet 2466 (87.4)
    Statin 2020 (71.6)
    Anticoagulation 
      (including intravenous)
1295 (45.9)
NIHSS score during admission
    Baseline NIHSS score      3 [1-6]
    NIHSS score at 1 day      2 [1-5]
    NIHSS score at 3 days      2 [0-5]
    NIHSS score at 7 days 
      (or final NIHSS score)
     1 [0-4]
    Delta: baseline-7 days 
      (or final NIHSS score)
     0 [0-2]
TOAST, Trial of Org 10172 in Acute Stroke Treatment; NIHSS, National 
Institutes of Health Stroke Scale.
Data are expressed as mean±SD, number (%), or median [interquartile 
range]. 
*Stroke mechanism was determined among 2545 ischemic stroke patients 
with acute ischemic lesion in brain imaging.
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sociated with short-term mortality. With adjustment for 
these potential confounders, the presence of END was an 
independent predictor of mortality at 30 days (odds ratio 
3.185, 95% CIs 1.522-6.664, p=0.002) (Table 2). However, 
END with recovery was not associated with mortality with-
in 30 days. Compared with no END, the development of 
severe END was more strongly associated with short-term 
mortality. Among the causes of END, brain herniation, re-
current stroke, ICH, and medical illness were associated 
with 30-day mortality, while worsening of the index stroke 
tion of patients who did not recover during hospitalization 
was greater in patients with brain herniation or medical ill-
ness compared to those with other causes (Fig. 1).
Short-term (30-day) mortality
With respect to 30-day mortality, age (p<0.001), previous 
ischemic heart disease (p=0.039), peripheral arterial occlu-
sive disease (p=0.006), atrial fibrillation (p<0.001), and 
baseline NIHSS score (p<0.001), as well as final NIHSS 
score (p<0.001) or delta NIHSS score (p<0.001), were as-
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Fig. 1. Frequency of (A) early neurologic deterioration (END) conditions and (B) END with recovery according to the causes of END. ICH, intracerebral hem-
orrhage.
Table 2. Multivariate Analysis According to END Characteristics 
30-day mortality (n=2820) Long-term mortality (n=2741)
Adjusted OR (95% CIs) p value* Adjusted HR (95% CIs) p value†
The presence of END 3.185 (1.522-6.664) 0.002 1.571 (1.165-2.119) 0.003 
Degree of END
    No END 1 1.000 
    END with increase in 1 NIHSS   5.300 (1.991-14.106) 0.001 1.759 (1.109-2.787) 0.016 
    END with increase in 2-3 NIHSS 3.141 (1.014-9.735) 0.047 1.396 (0.882-2.209) 0.154
    END with increase in ≥4 NIHSS   24.556 (13.213-45.635) <0.001 1.592 (1.022-2.480) 0.040 
Presence of recovery after END
    No END 1 1.000 
    END with recovery 1.638 (0.357-7.523) 0.525 1.611 (1.039-2.496) 0.033 
    END without recovery 16.427 (9.288-29.054) <0.001 1.546 (1.069-2.234) 0.020 
Causes of END
    No END 1 1.000 
    Herniation   32.135 (13.828-74.677) <0.001 1.383 (0.576-3.320) 0.468 
    Worsening of index stroke sx 0.981 (0.225-4.272) 0.980 1.379 (0.975-1.950) 0.069 
    Recurrent stroke 15.156 (5.478-41.933) <0.001 2.787 (1.589-4.888) <0.001
    Intracranial hemorrhage   26.483 (10.806-64.902) <0.001 1.341 (0.617-2.913) 0.458 
    Medical problem     39.187 (10.746-142.910) <0.001   4.704 (1.838-12.041) 0.001 
END, early neurological deterioration; NIHSS, National Institutes of Health Stroke Scale; OR, odds ratio; CI, confidence interval.
*Binary logistic regression model for the analysis of 30-day mortality adjusted for age, sex, previous ischemic heart disease, peripheral arterial occlusive 
disease, atrial fibrillation, and baseline NIHSS score in the study population.
†Cox proportional hazard model for the analysis of long-term mortality adjusted for age, sex, hypertension, diabetes, smoking, previous ischemic stroke, 
ischemic heart disease, peripheral arterial occlusive disease, stroke subtype, and baseline NIHSS score, as well as delta NIHSS score in stroke survivors.
  Mild END     Moderate END     Severe END   END with recovery     END without recovery 
p=0.001 p<0.001
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DISCUSSION
Previous studies have shown that initial stroke severity and 
functional status at discharge have a strong association with 
long-term mortality.2,5,18 Those associations were consis-
tently observed in our study in that the initial NIHSS score 
as well as delta NIHSS score were independent predictors 
of long-term mortality. Furthermore, we showed that pa-
tients who experienced neurologic deterioration while they 
were admitted due to acute ischemic stroke encompassed 
higher risks of short-term and long-term mortality, irrespec-
tive of initial stroke severity.
In our study, short-term and long-term mortality differed 
according to the characteristics of END. END followed by 
recovery was not associated with short-term mortality, but 
was associated with long-term mortality, while severe END 
with an increase of  ≥4 in NIHSS score was more associat-
ed with short-term mortality. Compared to END without re-
covery, END with recovery during the acute stage resulted 
in milder neurological disability at discharge. However, the 
risk of long-term mortality was similar regardless of whether 
the END was followed by recovery, although patients with-
out recovery were more severely disabled at discharge. Pre-
vious studies showed that patients with TIA or recovery 
within 24 hours after ischemic stroke had a greater risk of 
subsequent stroke or neurological deterioration.19,20 Our re-
sults along with previous findings suggest that END, with 
or without recovery in the acute stage, is a surrogate marker 
of recurrent vascular events and future mortality. 
We further demonstrated that the risk of future mortality 
varies according to the etiology of END. Among the etiol-
ogies of END, brain herniation and ICH were associated 
was not. In multivariate analyses, according to each charac-
teristic of END, baseline NIHSS score was a significant 
and independent predictor of short-term mortality (data not 
shown).
Long-term mortality in stroke survivors
Univariate Cox proportional hazard model revealed that 
age (p<0.001), hypertension (p=0.031), diabetes (p=0.001), 
smoking (p=0.009), previous ischemic stroke (p<0.001), 
ischemic heart disease (p=0.001), peripheral arterial occlu-
sive disease (p<0.001), stroke subtype (p<0.001), baseline 
NIHSS (p<0.001), and final NIHSS score (p<0.001) were 
related to long-term mortality among stroke survivors. In 
multivariate Cox proportional hazard model, END itself 
was an independent predictor of long-term mortality (HR 
1.571, 95% CIs 1.165-2.119). In contrast to the results for 
short-term mortality, the long-term risk of mortality was not 
different according to the severity of END or the presence 
of recovery after END (Table 2). Among the causes of 
END, recurrent stroke and medical illness remained inde-
pendent, while brain herniation and ICH were not associat-
ed with long-term mortality. On multivariate analysis of the 
relationship between each characteristic of END and long-
term mortality, baseline NIHSS score and delta NIHSS 
score remained independent and significant predictors of 
long-term morality (data not shown). 
Fig. 2 shows the adjusted survival curves for all-cause 
mortality in stroke survivors. Survival was similar between 
patients who did not recover after END and those who re-
covered after END and between the patients who devel-
oped mild END and those who developed severe END. 
However, among the etiologies of END, patients with med-
ical illness and recurrent stroke showed poorer survival. 
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Fig. 2. Adjusted survival curves for long-term mortality in stroke survivors according to (A) severity of early neurologic deterioration (END), (B) presence of 
recovery after END, and (C) causes of END. ICH, intracerebral hemorrhage.
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findings also suggest that the prediction of mortality differs 
depending on the etiology of END. Physicians should con-
cern about patients with END in order to prevent devastat-
ing events.
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